The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy
There is an urgent need to develop new combination therapies beyond existing surgery, radio‐ and chemo‐therapy, perhaps initially combining chemotherapy with the targeting specificities of immunotherapy. For this, strategies to limit inflammation and immunosuppression and evasion in the tumour micro...
Main Authors: | Moore, Colin, Kosgodage, Uchini S., Lange, Sigrun, Inal, Jameel |
---|---|
Format: | Article |
Published: |
Wiley
2017
|
Subjects: |
Similar Items
-
Cannabidiol (CBD) is a novel inhibitor for Exosome and Microvesicle (EMV) release in cancer
by: Kosgodage, Uchini S., et al.
Published: (2018) -
A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy
by: Kholia, Sharadkumar Rajnikant, et al.
Published: (2015) -
The role of PADs in the biogenesis of prostate cancer microvesicles which play a dysfunctional role on DC biology and the therapeutic potential of skeletal muscle microvesicles on prostate cancer cells
by: Kholia, Sharadkumar Rajnikant
Published: (2014) -
The role of microvesicles in cancer and viral infection
by: Jorfi, Samireh
Published: (2012) -
Development of novel isolation methodologies for microvesicles and exosomes, as potential biomarkers for health (Therapeutic Lifestyle Changes), and use of microvesicle-delivered β-Gly in erythroleukaemia
by: Grant, Ryan Conrad
Published: (2016)